Why are drug prices so high? Investigating th...

Mark Rober spent years trying to land a rover on Mars. Now, the former NASA engineer turned science YouTuber with millions of subscribers is launching a new mission: to teach the next generation of big problem solvers. That's why he's spending 60 million dollars to build a STEM c ...  Show more

What if the path to peace starts with self-interest? After four decades inside some of the world's most dangerous conflict zones, mediator Hiba Qasas has learned that most peacebuilding efforts get it wrong from the start. She makes a provocative case that conciliation shouldn't ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...